Credit Suisse Ag Heron Therapeutics, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$1.51 - $3.25 $21,186 - $45,600	14,031 Added 11.67%	134,234 $202,000
Q4 2022 Feb 13, 2023	SELL	$2.25 - $4.67 $40,531 - $84,125	-18,014 Reduced 13.03%	120,203 $300,000
Q3 2022 Nov 10, 2022	BUY	$2.66 - $5.37 $54,080 - $109,177	20,331 Added 17.25%	138,217 $583,000
Q2 2022 Aug 12, 2022	SELL	$2.3 - $6.29 $41,278 - $112,886	-17,947 Reduced 13.21%	117,886 $328,000
Q1 2022 May 16, 2022	SELL	$4.63 - $9.94 $34,396 - $73,844	-7,429 Reduced 5.19%	135,833 $776,000
Q4 2021 Feb 14, 2022	BUY	$8.35 - $12.6 $290,964 - $439,059	34,846 Added 32.14%	143,262 $1.31 Million
Q3 2021 Nov 12, 2021	BUY	$10.13 - $15.0 $261,647 - $387,435	25,829 Added 31.27%	108,416 $1.16 Million
Q2 2021 Aug 16, 2021	BUY	$13.27 - $18.48 $229,783 - $319,999	17,316 Added 26.53%	82,587 $1.28 Million
Q1 2021 May 14, 2021	SELL	$14.49 - $20.72 $1.15 Million - $1.64 Million	-79,098 Reduced 54.79%	65,271 $1.06 Million
Q4 2020 Feb 12, 2021	SELL	$14.61 - $22.14 $236,594 - $358,535	-16,194 Reduced 10.09%	144,369 $3.06 Million
Q3 2020 Nov 13, 2020	BUY	$13.67 - $17.77 $22,254 - $28,929	1,628 Added 1.02%	160,563 $2.38 Million
Q2 2020 Aug 12, 2020	BUY	$10.89 - $21.47 $440,391 - $868,246	40,440 Added 34.13%	158,935 $2.34 Million
Q1 2020 May 13, 2020	SELL	$10.23 - $24.56 $687,261 - $1.65 Million	-67,181 Reduced 36.18%	118,495 $1.39 Million
Q4 2019 Feb 12, 2020	BUY	$17.42 - $26.61 $1.96 Million - $3 Million	112,634 Added 154.2%	185,676 $4.36 Million
Q3 2019 Nov 12, 2019	BUY	$16.36 - $21.39 $416,083 - $544,011	25,433 Added 53.42%	73,042 $1.35 Million
Q2 2019 Aug 14, 2019	SELL	$16.93 - $26.22 $129,108 - $199,953	-7,626 Reduced 13.81%	47,609 $885,000
Q1 2019 May 14, 2019	SELL	$23.15 - $28.34 $890,580 - $1.09 Million	-38,470 Reduced 41.05%	55,235 $1.35 Million
Q4 2018 Feb 13, 2019	BUY	$22.03 - $32.01 $810,748 - $1.18 Million	36,802 Added 64.67%	93,705 $2.43 Million
Q3 2018 Nov 13, 2018	BUY	$30.0 - $40.85 $33,630 - $45,792	1,121 Added 2.01%	56,903 $1.8 Million
Q2 2018 Aug 14, 2018	SELL	$26.4 - $42.0 $153,410 - $244,062	-5,811 Reduced 9.43%	55,782 $2.17 Million
Q1 2018 May 15, 2018	BUY	$18.43 - $28.8 $237,175 - $370,627	12,869 Added 26.41%	61,593 $1.7 Million
Q4 2017 Feb 14, 2018	SELL	$14.8 - $18.85 $187,945 - $239,376	-12,699 Reduced 20.67%	48,724 $881,000
Q3 2017 Nov 14, 2017	SELL	$14.65 - $16.85 $561,402 - $645,708	-38,321 Reduced 38.42%	61,423 $992,000
Q2 2017 Aug 14, 2017	BUY	N/A	99,744	99,744 $1.38 Million

Others Institutions Holding HRTX

# of Institutions

179

Shares Held

121M

Call Options Held

80.4K

Put Options Held

94.9K

Rubric Capital Management LP New York, NY

26.7M
Shares

$41.4 Million
1.48% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

8.85M
Shares

$13.7 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

8.72M
Shares

$13.5 Million
0.0% of portfolio
Black Rock Inc. New York, NY

8.33M
Shares

$12.9 Million
0.0% of portfolio
Velan Capital Investment Management LP Alpharetta, GA

6.99M
Shares

$10.8 Million
28.8% of portfolio

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $184M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account